DIPIRO's Pharmacotherapy. A Pathophysiologic Approach

Dedication
Contents
Contributors
Foreword
Preface
Section 1. Foundation Issues
1. Patient Care Process
e2. Health Literacy and Medication Use
e3. Exploring Cultural Diversity and Equity in Healthcare
e4. Medication Safety
e5. Medication Adherence
e6. Clinical Pharmacokinetics and Pharmacodynamics
e7. Clinical Pharmacogenomics
e8. Clinical Toxicology
Section 2. Common Health Problems
e9. Fever
e10. Pain and Headache
e11. Minor Ophthalmic Disorders
e12. Minor Otic Disorders (Cerumen Impaction, Otitis External)
e13. Nonspecific Respiratory Tract Symptoms (with Cough)
e14. Allergic Rhinitis
e15. Oral Health and Systemic Conditions
e16. Oral Hygiene and Minor Oral Disorders
e17. Skin Care and Minor Dermatologic Conditions
e18. Travel Health
19. Contraception
Section 3. Special Populations
e20. Pediatrics: General Topics in Pediatric Pharmacotherapy
e21. Pediatrics: Oral Nutrition and Rehydration of Infants and Children
e22. Pediatrics: Neonatal Critical Care
e23. Geriatrics: Physiology of Aging
e24. Geriatrics: Medication Use in Older Adults
e25. Geriatrics: Assessing Health and Delivering Healthcare to Older Adults
e26. Critical Care: Considerations in Medication Selection, Dosing, Monitoring, and Safety
e27. Critical Care: Pain, Agitation, and Delirium
e28. Palliative and End-of-Life Care
Section 4. Cardiovascular Disorders
e29. Evaluation of Cardiovascular Function
30. Hypertension
e31. Acute Hypertensive Crisis
32. Dyslipidemia
33. Stable Ischemic Heart Disease
34. Acute Coronary Syndrome
e35. Peripheral Arterial Disease
36. Chronic Heart Failure
37. Acute Decompensated Heart Failure
38. Venous Thromboembolism
39. Stroke
40. Arrhythmias
41. Cardiopulmonary Arrest
e42. Shock Syndromes
Section 5. Respiratory Disorders
e43. Evaluation of Respiratory Function
44. Asthma
45. Chronic Obstructive Pulmonary Disease
46. Pulmonary Arterial Hypertension
47. Cystic Fibrosis
e48. Drug-Induced Pulmonary Diseases
Section 6. Gastrointestinal Disorders
e49. Evaluation of the Gastrointestinal Tract
50. Gastroesophageal Reflux Disease
51. Peptic Ulcer Disease and Related Disorders
52. Inflammatory Bowel Disease
53. Nausea and Vomiting
54. Diarrhea, Constipation, and Irritable Bowel Syndrome
55. Portal Hypertension and Cirrhosis
e56. Drug-Induced Liver Injury
57. Pancreatitis
58. Viral Hepatitis
59. Celiac Disease
Section 7. Renal Disorders
e60. Evaluation of Kidney Function
61. Acute Kidney Injury
62. Chronic Kidney Disease
63. Chronic Kidney Disease: Management of Secondary Complications
64. Hemodialysis and Peritoneal Dialysis
65. Drug-Induced Kidney Disease
e66. Glomerular Diseases
67. Personalized Pharmacotherapy for Patients with Chronic Kidney Disease
68. Disorders of Sodium and Water Homeostasis
69. Disorders of Calcium and Phosphorus Homeostasis
70. Disorders of Potassium and Magnesium Homeostasis
71. Acid–Base Disorders
Section 8. Neurologic Disorders
e72. Evaluation of Neurological Illness
73. Alzheimer Disease
74. Multiple Sclerosis
75. Epilepsy
76. Status Epilepticus
77. Acute Management of the Brain Injury Patient
78. Parkinson Disease
79. Pain Management
80. Headache Disorders
Section 9. Psychiatric Disorders
e81. Evaluation of Psychiatric Illness
82. Attention Deficit Hyperactivity Disorder
e83. Eating Disorders
e84. Introduction to Substance Use Disorders
85. Substance Use Disorders I: Opioids, Cannabis, and Stimulants
86. Substance Use Disorders II: Alcohol, Nicotine, and Caffeine
87. Schizophrenia
88. Depressive Disorders
89. Bipolar Disorder
90. Generalized Anxiety Disorder, Panic Disorder, and Social Anxiety Disorder
91. Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder
92. Sleep Disorders
e93. Developmental Disabilities
Section 10. Endocrinologic Disorders
94. Diabetes Mellitus
e95. Acute Hyperglycemia
96. Thyroid Disorders
97. Adrenal Gland Disorders
e98. Pituitary Gland Disorders
Section 11. Gynecologic and Obstetric Disorders
99. Pregnancy and Lactation
100. Menstrual-Related Disorders
101. Endometriosis
102. Menopausal Hormone Therapy
Section 12. Urologic Disorders
103. Erectile Dysfunction
104. Benign Prostatic Hyperplasia
105. Urinary Incontinence
Section 13. Immunologic Disorders
e106. Function and Evaluation of the Immune System
107. Systemic Lupus Erythematosus
e108. Drug Allergy
109. Solid-Organ Transplantation
Section 14. Rheumatologic Disorders
110. Osteoarthritis
111. Rheumatoid Arthritis
112. Osteoporosis
113. Gout and Hyperuricemia
Section 15. Ophthalmic Disorders
114. Glaucoma
115. Age-Related Macular Degeneration
e116. Drug-Induced Ophthalmic Disorders
Section 16. Dermatologic Disorders
117. Acne Vulgaris
118. Psoriasis
119. Atopic Dermatitis
120. Alopecia
e121. Dermatologic Drug Reactions, Contact Dermatitis, and Common Skin Conditions
Section 17. Hematologic Disorders
122. Anemias
123. Coagulation Disorders
124. Sickle Cell Disease
e125. Drug-Induced Hematologic Disorders
Section 18. Infectious Diseases
e126. Laboratory Tests to Direct Antimicrobial Pharmacotherapy
127. Antimicrobial Regimen Selection
128. Central Nervous System Infections
129. Lower Respiratory Tract Infections
130. Upper Respiratory Tract Infections
131. Influenza
e132. Coronavirus Disease (COVID-19)
133. Skin and Soft Tissue Infections
134. Bacteremia and Infective Endocarditis
135. Tuberculosis
136. Gastrointestinal Infections and Enterotoxigenic Poisonings
137. Intra-Abdominal Infections
e138. Parasitic Diseases
139. Urinary Tract Infections
140. Sexually Transmitted Infections
141. Bone and Joint Infections
142. Sepsis and Septic Shock
143. Superficial Fungal Infections
144. Invasive Fungal Infections
145. Infections in Immunocompromised Patients
146. Antimicrobial Prophylaxis in Surgery
147. Vaccines and Immunoglobulins
148. Human Immunodeficiency Virus Infection
Section 19. Oncologic Disorders
149. Cancer: The Disease and Treatment
150. Supportive Care in Cancer
151. Breast Cancer
152. Lung Cancer
153. Colorectal Cancer
154. Prostate Cancer
155. Lymphomas
156. Ovarian Cancer
157. Acute Leukemias
158. Chronic Leukemias
159. Multiple Myeloma
e160. Myelodysplastic Syndromes
e161. Renal Cell Carcinoma
162. Melanoma
e163. Hematopoietic Cell Transplantation
Section 20. Nutritional Disorders
164. Assessment of Nutrition Status and Nutrition Requirements
165. Parenteral Nutrition
166. Enteral Nutrition
167. Obesity
Index

 

This new edition of the authoritative pharmacotherapy text has been fully updated with the latest evidence-based information and recommendations

 

For more than 30 years, Dipiro’s Pharmacotherapy has been the essential textbook for learning how to properly select, administer, and monitor drugs?everything needed to provide safe, effective drug therapy across all therapeutic categories.

 

With content from 300 expert contributors, it offers detailed descriptions of common and uncommon disease states, including treatment by pharmacologic and non-pharmacologic means. Each disease chapter opens with Patient Care Process, helping readers understand the collaborative care model in which pharmacists work and communicate with other healthcare providers for effective coordinated care.

 

Features

• Loaded with pedagogy to help students fully master concepts and practices
• Key concepts begin each chapter
• Includes algorithms, dosing recommendations, and monitoring approaches
• Diagnostic flow diagrams, treatment algorithms, dosing guideline recommendations, and monitoring approaches updated in full color to clearly distinguish treatment pathways
• New drug monitoring tables have been added
• Patient care process boxes help readers know how to communicate with other health care providers